In breast cancer P-cadherin overexpression is correlated with reduced tumor growth in mice and bad prognosis in human patients when E-cadherin is co-expressed in the tumor, whereas the expression of P-cadherin or E-cadherin alone displayed reduced cancer growth. Here, CDH3 is linked to breast cancer.